Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01937923 · ClinicalTrials.gov registry record
A Pre-Cellular Therapy Observational Study in Early Huntington's Disease
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 29
- Enrollment target
NCT01937923: Completed study, sponsored by University of California, Davis.
NCT01937923 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01937923 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This observational study will establish a clinical baseline and measure changes over time in movement, thinking, behavior, brain imaging, blood and spinal fluid markers in subjects with early stage Huntington's disease. Participants enrolled in this study may be eligible to participate in a future planned study of stem cell therapy for Huntington's Disease (HD). In-person study visits occur at screening, baseline, and every 6 months thereafter for a minimum of 12 months, with interim phone call assessments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-07 |
What the finished NCT01937923 record still lists
NCT01937923 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01937923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01937923 about?
NCT01937923 is a clinical study titled "A Pre-Cellular Therapy Observational Study in Early Huntington's Disease". This observational study will establish a clinical baseline and measure changes over time in movement, thinking, behavior, brain imaging, blood and spinal fluid markers in subjects with early stage Huntington's disease. Participants enrolled in this study may be eligible to participate in a future p...
What is the current status of trial NCT01937923?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2013-08. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT01937923?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia